Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer: Retrospective Data Analysis from an Indian Centre

Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer: Retrospective Data Analysis from an Indian Centre

Objective: To determine the efficacy and safety of cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) patients from the named patient programme (NPP) at our centre. Methods: mCRPC patients who progressed on docetaxel were given cabazitaxel intravenously every 3 weeks until diseas...

Full description

Bibliographic Details
Main Authors: Vanita Noronha, Amit Joshi, Vamshi Krishna Muddu, Vijay Maruti Patil, Kumar Prabhash
Format: Article
Language:English
Published: Karger Publishers 2016-08-01
Series:Case Reports in Oncology
Subjects:
Cabazitaxel
Prostate-specific antigen
Disease-free survival
Neutropenia
Leucopenia
Online Access:http://www.karger.com/Article/FullText/447710

Internet

http://www.karger.com/Article/FullText/447710

Similar Items